Raymond James Financial
PACB icon

Raymond James Financial’s Pacific Biosciences PACB Stock Holding History

Raymond James Financial’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
164,558
-18,720
-10% -$33.5K ﹤0.01% 4847
2025
Q4 		$343K Buy
183,278
+21,413
+13% +$41.1K ﹤0.01% 4489
2025
Q3 		$207K Buy
161,865
+9,896
+7% +$13.4K ﹤0.01% 4605
2025
Q2 		$188K Buy
151,969
+21,863
+17% +$25.2K ﹤0.01% 4546
2025
Q1 		$154K Sell
130,106
-8,010
-6% -$12.3K ﹤0.01% 4478
2024
Q4 		$253K Buy
+138,116
New +$270K ﹤0.01% 4281

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return